GOLD REPORT of June 22, 2017

  • Achiievers

Market Commentary Gold on MCX settled up 0.18% at 28577 prices paused after a recent downtrend gained in yesterday session marginally but still holding near 5-week lows in the absence of market-moving economic data. The dollar wobbled a bit in yesterday’s...

  • 0 Comments
  • Share to Facebook
Read More

Mid Night News – 19th Jun 2017

  • Achiievers

 Midnight News Update – Jun 19th 2017   The finance minister has affirmed the rollout of GST will happen as scheduled on July 01st with the last meeting of the Council happening on 30th June. While the FM has ruled out any relaxation on...

  • 0 Comments
  • Share to Facebook
Read More

GOLD REPORT AS ON 13062017

  • Achiievers

Market Commentary Gold prices traded in range as investors remained cautious ahead of a two-day U.S. Federal Reserve meeting that is likely to provide hints on the central bank's interest rate policy for the remainder of the year. The Fed starts a...

  • 0 Comments
  • Share to Facebook
Read More

Invest in Aurobindo Pharma Ltd – return 27% within 1 year

  • Achiievers

Aurobindo Pharma is one of the largest vertically integrated pharmaceutical companies with API integration for over 75% of its products. Over the past few years, the company has drastically shifted its focus from API business to formulations. Hence, the...

  • 0 Comments
  • Share to Facebook
Read More

Buy signal on Sun Pharma Ltd

  • Achiievers

Company Overview Sun Pharma is world's fifth largest specialty generic and India's top pharmaceutical company with global presence supported by 49 manufacturing facilities spread across 6 continents. Company has expanded both organically and through...

  • 0 Comments
  • Share to Facebook
Read More

Monetary Policy Highlights

  • Achiievers

2nd Bi-monthly FY 2015-16 Monetary Policy Highlights   Reserve Bank announced the following policy measures: Second Bi-monthly FY 2014-15 Monetary Policy Highlights:  Repo rate reduced by 25 bps to 7.25%. Consequently, the reverse repo...

  • 0 Comments
  • Share to Facebook
Read More